| abstract |
The present invention relates to: a compound selected from the group consisting of tricyclic compounds having the structure of formula I, pharmaceutically acceptable salts, isomers, solvates and precursors thereof; and uses thereof. The compounds are effective in controlling GPR40, and thus can be useful in the prevention or treatment of diseases associated with GPR40, for example, diabetes and many other diseases. |